Organoids accelerate the search for antiviral drugs
Finding drugs for outbreaks of new virusses often takes a lot of time. Researchers at Erasmus MC now show that this process can be sped up using organoids: miniature versions of human organs. Thanks to new techniques, these can now be used to expeditiously identify antiviral drugs.
DNA test: who benefits from chemotherapy for ovarian cancer?
Why does chemotherapy work for some patients and not for others? Researchers at Erasmus MC have found a promising clue in the dividing DNA of cancer cells. They hope this will enable them to predict which women with ovarian cancer will truly benefit from chemotherapy.
New mechanism in BRCA2 tumors discovered: why chemotherapy sometimes fails
Why do some BRCA2 tumors eventually stop responding to chemotherapy? Researchers at Erasmus MC discovered how these tumors are still able to repair their DNA damage and how they evade the effects of chemotherapy.
New Erasmus MC Subsidiary Develops Personalized Immunotherapy
Erasmus MC has established a new company dedicated to developing a new form of immunotherapy. This new therapy — a personalized cancer vaccine — is intended for patients with pancreatic cancer.
Scientists at Erasmus MC have discovered that von Willebrand disease, the most common inherited bleeding disorder, is not always caused by a genetic defect in the von Willebrand factor gene. Defects in the mechanisms that control secretion of this hemostatic protein can also cause von Willebrand disease, they show.
Zhenyu wants to know how our brains control movements
Picking up a cup or putting one foot in front of the other: even the simplest movements require a lot of calculations from our brains. Scientist Zhenyu Gao wants to know how this works in the brain. He challenges traditional ideas in the process. ‘Brain parts are not separate lego blocks.’
Focus on Societal Challenges as driver of Research
As a university medical center, Erasmus MC has a great responsibility to help solve social issues related to health. The research strategy 2023-2029 ‘Focus on Societal Challenges as driver op Research’, clarifies the direction we want to take as a scientific organization at the center of society.
The strategy, which is in line with Erasmus MC’s mission and core values, describes how we can increase the impact of our research and strategically deploy the limited resources available for scientific research. And how we, together with our stakeholders, can effectively contribute to solutions, now and in the future.